ReviewTranslational oncology2026
Gap junctions and hemichannels in cancer: A "Wired versus Broadcast" framework for tumor microenvironment routing of cGAMP-STING signals and therapy response.
Review in Translational oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intercellular communication in the tumor microenvironment (TME) dictates cancer progression, immune evasion, and therapy response. Gap junctions (GJs, primarily connexins), connexin hemichannels, and pannexin channels have been widely reviewed, but a unified conceptual model that contrasts protected "Wired" versus vulnerable "Broadcast" routing of cGAMP and ATP in the TME, and links this routing to therapy response, has been lacking. We propose a "Wired vs Broadcast" framework to define the routing of TME danger signals. "Wired" signaling, via connexin 43 (Cx43) gap junction intercellular communication, mediates contact-dependent, protected transfer of the immunotransmitter 2´3´-cGAMP from tumor cells to recipient cells, activating the STING pathway. "Broadcast" signaling, via PANX1 channels and related extracellular release routes, releases ATP and extracellular cGAMP into the TME, where they are intercepted and neutralized by ectoenzymes such as ENPP1 and CD39/CD73. This framework highlights context-dependent, recipient-cell-dependent outcomes of "Wired" signaling: a tumor-to-antigen-presenting cell (APC) "Wired" circuit can drive anti-tumor immunity and support immune checkpoint blockade (ICB) responsiveness, whereas a tumor-to-astrocyte "Wired" circuit can promote brain metastasis and chemoresistance. The relative contributions of "Wired" and "Broadcast" routing, shaped by cellular proximity, scaffolding proteins, transport and uptake mechanisms, and ectoenzyme expression, may influence therapeutic response in a context-dependent manner. This review synthesizes current evidence into an integrative and testable "Wired versus Broadcast" framework and discusses biomarker and combination-therapy hypotheses that can be evaluated in forthcoming spatial-omics and clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.